History
Buerger disease (thromboangiitis obliterans) is a disease in which inflammation and blood clots repeatedly occur in the small and medium-sized arteries and veins of the hands and feet, reducing blood flow to the extremities. Today, it is more accurate to understand it not as "a disease in which blood vessels narrow" but as "a disease in which inflammation and blood clots occur together inside blood vessels and block them." Historically, this disease originated from attempts to explain cases of gangrene of the toes and fingers in young people. In the late 19th century, Felix von Winiwarter reported vascular lesions in a patient with unusual gangrene of the extremities, and in 1908, Leo Buerger systematically described the pathological findings based on amputation specimens, making the concept of the disease widely known.
Since then, the medical community has long debated how to distinguish Buerger disease from atherosclerosis and whether to regard it as a "vasculitis" or a "thrombotic disease." In clinical practice, it has been repeatedly emphasized that the blood vessels at the ends of the hands and feet are blocked "segmentally," that large blood vessels elsewhere in the body are often relatively preserved, and that superficial phlebitis can occur at the same time. Before imaging tests advanced, diagnosis was often delayed, and it was common for the diagnosis to be confirmed only after pain and ulcers had worsened and amputation had become necessary.
After vascular ultrasound and angiography became widespread, it became possible to suspect the disease early by looking at the pattern of occlusion in the distal blood vessels and the shape of the collateral vessels. Recent research has placed more emphasis on endothelial cell dysfunction and immune dysregulation as the central mechanisms of Buerger disease, and there has been an increase in research that seeks to explain not simply "the result of blocked blood vessels" but "why inflammatory blood clots recur inside blood vessels."
Causes
The most certain fact in discussions of the cause of Buerger disease is its strong association with tobacco exposure. Not only regular cigarettes but also smokeless tobacco, e-cigarettes, and in some cases cannabis smoking have been reported together with a similar pattern of peripheral vasculitis. The most practical conclusion for patients in clinical practice is simple: "If you keep smoking, the disease is likely to keep progressing, and only quitting smoking can change its course."
Nevertheless, the cause cannot be explained by tobacco alone. This is because, even with the same level of smoking, some people develop the disease and others do not. Therefore, the cause is usually explained as an interplay between "the immune response triggered by tobacco" and "constitutional changes that make blood clots form easily." When tobacco components and combustion byproducts irritate the vascular endothelium, the endothelium sends out inflammatory signals and enters a state in which immune cells easily adhere to the blood vessels.
Another perspective is that of an "accompanying chronic inflammatory environment." It has been proposed that chronic inflammation such as gum disease (periodontal disease), recurrent infections, or a systemic inflammatory state can worsen endothelial injury and affect the onset of Buerger disease. In actual clinical practice, the diagnosis is not made automatically just because the patient is "a young person who smokes"; other vascular diseases are ruled out first.
Recent research emphasizes endothelial cell activation as the core axis of the disease, and tobacco exposure is described as the main environmental factor that maintains and worsens this endothelial activation and prothrombotic state. Therefore, the goal of managing the cause is not "cutting down on smoking a little" but "completely stopping nicotine/tobacco exposure," and this is the common starting point for both treatment and prevention.
Genetic Epidemiology
Buerger disease is not a typical genetic disease that can be explained by family history alone. That said, it is also difficult to conclude that there are no genetic factors at all. The reason is simple: despite the strong environmental factor of tobacco exposure, whether the disease develops differs from person to person. Therefore, it is natural to understand genetic epidemiology not as "a single specific gene causes the disease" but from the perspective of vulnerability, that is, "in some people, endothelial, immune, and coagulation responses may react more excessively to the stimulus of smoking."
Recent research emphasizes that in Buerger disease, when endothelial cells are activated, immune cells adhere more readily to the vessel wall, and inflammation and blood clots can persist. In this process, molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) increase, and when an environment of inflammatory cytokines and reactive oxygen species (ROS) is created, the inside of the blood vessel becomes an environment that "clots" more easily. Individual differences in this molecular reactivity may not be unrelated to genetic background, but in current clinical practice, it has not reached the stage of confirming this with standard genetic tests or quantifying the risk.
The important message for patients is not "It is genetic, so nothing can be done" but "Even if there is a constitutional vulnerability, stopping tobacco exposure can greatly change the prognosis." In other words, genetic epidemiology is highly meaningful from the perspective of prevention and education in explaining that "vulnerability may exist, but controllable factors matter more." In Buerger disease, a more powerful point of intervention than genetics is quitting smoking.
General Epidemiology
Buerger disease is reported worldwide, but its frequency varies by region, era, and smoking culture. Traditionally, it has been known to be common in young male smokers, and in fact, many reports show a high proportion of men. However, as smoking patterns change, female patients are also being reported, and assuming it is "a disease only of young men" can delay diagnosis. Lesions occur mainly in the small and medium-sized arteries and veins at the ends of the hands and feet, and repeated involvement of multiple limbs, rather than involvement of only one limb, is an important clue in clinical practice.
Epidemiologically, the scenario that raises suspicion of Buerger disease is relatively typical: (1) a relatively young age group, (2) a history of smoking (or recent smoking), and (3) recurring pain, coldness, color changes, and ulcers in the extremities such as the toes and fingers. Conversely, if the person is elderly, has clear diabetes, hyperlipidemia, and hypertension, and has obvious atherosclerosis of large blood vessels such as the aorta, iliac arteries, and femoral arteries, atherosclerotic peripheral artery disease is more common.
Recent research points out that diagnostic criteria are not fully unified across countries and that, because there is no definitive biomarker, the "number of reported patients" may differ from the true incidence. Ultimately, the most important message of general epidemiology for patients is: "If a young person who smokes has wounds on the ends of the hands or feet that do not heal well or has recurring pain, it should not be regarded merely as a skin problem; a peripheral vascular problem should be checked."
Pathogenesis
The pathogenesis of Buerger disease can be summarized as a repeating process of "inflammation + blood clots + occlusion of distal blood vessels." Histologically, the findings emphasized are that the blood clots inside the vessels are rich in inflammatory cells, while the vessel wall itself is relatively preserved compared with other forms of vasculitis. Because of this feature, Buerger disease is sometimes understood as an unusual disease that lies somewhere between "vasculitis, in which the vessel wall breaks down," and "atherosclerosis, in which vessels simply narrow as fatty deposits build up."
Recent research presents endothelial cell activation as the central link in the disease. When endothelial cells are activated, adhesion molecules (such as ICAM-1 and VCAM-1) that serve as a "foothold" for immune cells to attach increase, inflammatory signals are amplified, and the environment inside the blood vessels changes in a direction that promotes blood clotting. This process is linked to cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), and as oxidative stress increases, reactive oxygen species (ROS) increase and nitric oxide (NO) signaling weakens, so the blood vessels may constrict further and blood flow may decrease further.
In this environment, small distal blood vessels become blocked easily, and although the body tries to create bypass vessels (collateral vessels), tissue ischemia persists if these are not sufficient. As ischemia persists, pain develops, the skin becomes thin as its nutrient supply decreases, and even small wounds grow into ulcers. When inflammation and ischemia persist together, infection becomes more likely, which can eventually lead to gangrene.
Recent research mentions the possibility that approaches such as stem cell therapy may help endothelial function and vascular regeneration, while emphasizing that larger validation is needed to determine whether mechanistic expectations translate directly into long-term clinical effects. Therefore, the core of the pathogenesis is "a vicious cycle in which endothelial activation and a prothrombotic environment are maintained under tobacco exposure," and the core of treatment must also be aimed at breaking this vicious cycle.
Symptoms
The symptoms of Buerger disease begin with insufficient blood flow (ischemia) and tend to shift toward "pain, wounds, and gangrene" as the disease progresses. In the early stage, intermittent claudication, in which the calf or sole of the foot hurts when walking and the pain goes away with rest, is typical. In the upper limbs as well, similar pain can occur in the forearm or hand with repeated use of the hand. Patients at this stage often say things like "It hurts especially on cold days" or "My feet feel cold and numb."
As the disease progresses, pain at rest appears, and in some cases the pain becomes especially severe at night. This may be a sign that the state in which tissues do not receive enough oxygen has become more severe. In addition, as in Raynaud phenomenon, the color of the fingers and toes may change (pale, blue, then red) in response to cold or stress, accompanied by numbness or pain.
On the skin, small wounds may not heal well, painful ulcers may form on the tips of the fingers and toes, and the area around the wounds may easily become infected. When ulcers deepen and blood flow decreases further, the condition progresses to gangrene, at which point amputation may become necessary. Another characteristic symptom is migratory superficial thrombophlebitis, in which painful red nodules form along the veins under the skin and may appear to move from one place to another.
Recent research emphasizes that Buerger disease is not just a matter of pain but can disrupt many areas of life, including wound care, infection management, sleep, and activity limitations. Therefore, symptoms should not be left at the level of "discomfort"; if distal ischemia is suspected, it should be evaluated early and followed by active management, including quitting smoking.
Signs
The signs that doctors check for in Buerger disease fall into three main categories. The first is physical findings of reduced distal blood flow, the second is trophic changes in the skin, nails, and hair, and the third is typical patterns on imaging and blood flow tests. On physical examination, peripheral pulses such as the dorsalis pedis artery or posterior tibial artery pulse may be weakened or absent, and the hands and feet may appear cold and pale or bluish. Thin, shiny skin and reduced hair are also findings suggesting reduced blood flow.
When distal ischemia persists for a long time, ulcers form on the tips of the fingers and toes, and signs of gangrene appear, in which the skin turns black. If the veins are also involved, tender nodules of migratory superficial thrombophlebitis may be seen. Reduced distal perfusion can be objectively assessed with the ankle-brachial index (ABI) or toe-brachial index (TBI), digital blood pressure, and pulse wave tests.
Because Buerger disease mainly affects small distal vessels, the ABI may decrease relatively less, so distal-focused indicators such as the TBI or digital blood pressure are sometimes more helpful. On angiography, segmental occlusion of the distal vessels and corkscrew-shaped collateral vessels are described as typical findings. This can be understood as the result of the body creating "winding detours" to bypass the blocked blood vessels.
Screening
The most important thing in screening for Buerger disease is "in whom it should be suspected." The key group is people who have a history of smoking (or recent smoking) and who have recurring pain, coldness, color changes, and ulcers at the ends of the hands and feet. Suspicion increases especially when such symptoms begin at a relatively young age. Conversely, in elderly people with many conditions such as diabetes, hypertension, and hyperlipidemia, and with findings suggesting problems in the large blood vessels above the calf, other causes are more common.
As screening tests, noninvasive blood flow tests are useful first. The ankle-brachial index (ABI), toe-brachial index (TBI), digital blood pressure, and Doppler ultrasound help objectively assess distal ischemia. In addition, if there is a wound, it is necessary to check for infection and progression of gangrene, and if the pain is severe, distinguishing whether it is rest pain or claudication (pain during activity) is used as a reference for staging.
Another key aspect of screening is to consider at the same time "dangerous causes that must be ruled out." Missing causes for which treatment is completely different, such as cardiac embolism, or causes requiring systemic treatment, such as systemic vasculitis or coagulation disorders, is dangerous. Recent research emphasizes that at the screening stage, "if suspicion is strong, objectively assessing distal blood flow, confirming typical imaging findings, and above all starting to quit smoking immediately" are important for the actual course of patients.
Diagnosis
Buerger disease is diagnosed by a combination of "clinical presentation + imaging + diagnosis of exclusion." First, the history is checked for smoking/nicotine exposure, and it is checked whether there are symptoms of distal ischemia in the hands and feet (intermittent claudication, rest pain, ulcers, gangrene) and venous symptoms (migratory thrombophlebitis). On examination, peripheral pulses, changes in skin temperature and color, trophic changes, and the location and shape of ulcers (centered on the distal parts) are evaluated.
Tests are performed step by step. Noninvasively, ischemia is confirmed with ABI/TBI, digital blood pressure, and Doppler ultrasound. Next, vascular imaging is used to confirm the site and pattern of occlusion, and CT angiography (CTA) or magnetic resonance angiography (MRA) can be helpful. Angiography is useful for confirming the typical pattern in the greatest detail, and segmental distal occlusion and corkscrew-shaped collateral vessels support the diagnosis.
Above all, the most important step is differential diagnosis. Atherosclerotic peripheral artery disease, emboli from the heart or proximal sites, other forms of vasculitis, Raynaud phenomenon associated with connective tissue disease, coagulation disorders, and peripheral vascular disease due to diabetic complications must be ruled out. The diagnosis of Buerger disease is most solid not on the basis of "a single test result" but "when typical features, exclusion, and imaging patterns come together."
Tissue examination (biopsy) is not commonly performed because wounds in areas of distal ischemia may not heal well, but it may be considered when the clinical presentation is atypical or when large blood vessels appear to be involved.
Treatment
The most important principle in the treatment of Buerger disease is complete smoking cessation. The effectiveness of treatment depends greatly on whether the patient quits smoking, and if smoking is not stopped, ulcers and gangrene can worsen even with repeated pain medications or procedures. Here, quitting smoking includes stopping not "only cigarettes" but all tobacco/nicotine exposure, including e-cigarettes and smokeless tobacco. Secondhand smoke can also have an effect, so adjustments to the living environment may be needed.
Basic treatment consists of controlling ischemic pain, managing wounds and infection, avoiding cold, and protecting the feet and hands. When ulcers form, dressings and treatment of infection are needed, and if gangrene progresses, removal of necrotic tissue (debridement) or amputation may be needed. It is safer to understand drug therapy not as a "fundamental treatment" but as "treatment that helps symptoms and wounds." For example, there is cited evidence that iloprost, a prostacyclin analogue, may help relieve ischemic rest pain and heal ulcers.
Surgery or endovascular treatment is technically difficult because many of the lesions of Buerger disease are distal, and the candidates for it are limited. Nevertheless, in some patients, endovascular recanalization or revascularization strategies may be selectively considered, and treatments to reduce pain and vasoconstriction, such as sympathectomy, are also sometimes considered. Although stem cell therapy and other approaches have been proposed in recent research, it is important in current patient education to make clear that quitting smoking remains the center of treatment.
Prognosis
Buerger disease is usually not immediately life-threatening, but it can greatly reduce quality of life due to distal ischemia, and in severe cases it can even lead to amputation. The prognosis depends more on "whether the patient quit smoking" than on what treatment was received. If smoking continues, distal blood flow impairment recurs, wounds do not heal, and eventually the risk of amputation due to gangrene and infection can increase. Conversely, if smoking cessation is maintained, worsening of symptoms decreases, and the likelihood of living without amputation increases.
Another factor that determines prognosis is the stage of the disease at the time of diagnosis. When there are already recurrent ulcers, advanced gangrene, and extensive occlusion of distal blood vessels, treatment is more difficult and the period of wound care may be longer. In addition, when other vascular risk factors such as diabetes, hyperlipidemia, and hypertension are present, circulation may become worse, making prognostic management more complex.
Recent research emphasizes that because endothelial activation and oxidative stress can be the axes that sustain the disease process, it is hard to say "the disease is over" just because pain has decreased for a short time, and that maintaining smoking cessation and caring for the feet and hands are needed in the long term. Therefore, the prognosis can be summarized as depending on how well "lifestyle management to prevent recurrence (quitting smoking + protecting the extremities)" becomes established.
Prevention
Prevention of Buerger disease largely overlaps with its cause. The most certain method of prevention is not to smoke, and if you already smoke, to quit completely as soon as possible. "Cutting down" may not be enough to stop the progression of the disease, and switching to e-cigarettes or smokeless tobacco also cannot be assumed to be a safe alternative. It is also desirable to reduce exposure to secondhand smoke.
In terms of lifestyle management, it is important to reduce factors that constrict the distal blood vessels. Because cold can constrict blood vessels and worsen symptoms, it is necessary to keep warm thoroughly and, especially in winter, to make a habit of keeping the feet and hands warm. In addition, because tight shoes, repeated friction, and small wounds can lead to ulcers, protecting the feet and hands and caring for wounds early are important.
Managing accompanying diseases is also an indirect method of prevention. Problems such as diabetes, hyperlipidemia, and hypertension can worsen the peripheral blood vessels overall, so they should be managed as well.
Finally, "recognizing warning signs quickly" is also part of prevention. If a young smoker has recurring pain, color changes, or delayed wound healing at the tips of the toes or fingers, receiving an early peripheral vascular evaluation can be a form of "prevention that prevents amputation." The key to prevention is not smoking and responding quickly to abnormal signs.